期刊
JOURNAL OF INFECTIOUS DISEASES
卷 209, 期 -, 页码 S28-S31出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jit532
关键词
pertussis vaccines; regulatory pathways; vaccine effectiveness
资金
- FDA
The resurgence of pertussis in the United States has stimulated considerable public health interest in developing new vaccination strategies to improve control of pertussis. The purpose of this article is to review the US Food and Drug Administration's regulatory framework for the prelicensure clinical evaluation of preventive vaccines and the clinical approaches that have been used to demonstrate effectiveness of US-licensed vaccines containing an acellular pertussis component.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据